Radiosensitization Effect of AGuIX, a Gadolinium-Based Nanoparticle, in Nonsmall Cell Lung Cancer
Yanan Du,Hao Sun,François Lux,Yi Xie,Liqing Du,Chang Xu,Hong Zhang,Ningning He,Jinhan Wang,Yang Liu,Géraldine Leduc,Tristan Doussineau,Kaihua Ji,Qin Wang,Zhenhua Lin,Yan Wang,Qiang Liu,Olivier Tillement,François Lux,Géraldine Leduc
DOI: https://doi.org/10.1021/acsami.0c16548
2020-12-16
Abstract:Radiotherapy is the main treatment for cancer patients. A major concern in radiotherapy is the radiation resistance of some tumors, such as human nonsmall cell lung cancer. However, the radiation dose delivered to the tumors is often limited by the possibility of collateral damage to surrounding healthy tissues. A new and efficient gadolinium-based nanoparticle, AGuIX, has recently been developed for magnetic resonance imaging-guided radiotherapy and has been proven to act as an efficient radiosensitizer. The amplified radiation effects of AGuIX nanoparticles appear to be due to the emission of low-energy photoelectrons and Auger electron interactions. We demonstrated that AGuIX nanoparticles exacerbated radiation-induced DNA double-strand break damage and reduced DNA repair in the H1299 nonsmall cell lung cancer cell line. Furthermore, we observed a significant improvement in tumor cell damage and growth suppression, under radiation therapy, with the AGuIX nanoparticles in a H1299 mouse xenograft model. This study paves the way for research into the radiosensitization mechanism of AGuIX nanoparticles and provides a scientific basis for the use of AGuIX nanoparticles as radiosensitizing drugs.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c16548?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c16548</a>.Effects of different concentrations of AGUIX nanoparticles on the growth of MRC5 cells and uptake of AGUIX nanoparticles, cell counts, representative images from the clonogenic assay, western blot analysis of apoptosis-related proteins 2h postirradiation, immunofluorescence images and measurement of γH2AX-foci and 53BP1-foci activated cells, TUNEL and immunohistochemistry staining, histological study of tumors, liver, lungs and heart, safety of AGuIX nanoparticles in vivo, FITC-labeled AGuIX biodistribution at 1, 4, 8, and 24 h following intravenous injection in nude mice, and material characterization data on AGuIX nanoparticles (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c16548/suppl_file/am0c16548_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology